Consensus Recommendations for the Clinical Application of Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Depression: (Consensus Statement)
Open accessThe DOI matches its Crossref record; 120 of the 120 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To provide expert recommendations for the safe and effective application of repetitive transcranial magnetic stimulation (rTMS) in the treatment of major depressive disorder (MDD). PARTICIPANTS: Participants included a group of 17 expert clinicians and researchers with expertise in the clinical application of rTMS, representing both the National Network of Depression Centers (NNDC) rTMS Task Group and the American Psychiatric Association Council on Research (APA CoR) Task Force on Novel Biomarkers and Treatments. EVIDENCE: The consensus statement is based on a review of extensive literature from 2 databases (OvidSP MEDLINE and PsycINFO) searched from 1990 through 2016. The search terms included variants of major depressive disorder and transcranial magnetic stimulation. The results were limited to articles written in English that focused on adult populations. Of the approximately 1,500 retrieved studies, a total of 118 publications were included in the consensus statement and were supplemented with expert opinion to achieve consensus recommendations on key issues surrounding the administration of rTMS for MDD in clinical practice settings. CONSENSUS PROCESS: In cases in which the research evidence was equivocal or unclear, a consensus decision on how rTMS should be administered was reached by the authors of this article and is denoted in the article as "expert opinion." CONCLUSIONS: Multiple randomized controlled trials and published literature have supported the safety and efficacy of rTMS antidepressant therapy. These consensus recommendations, developed by the NNDC rTMS Task Group and APA CoR Task Force on Novel Biomarkers and Treatments, provide comprehensive information for the safe and effective clinical application of rTMS in the treatment of MDD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Repetitive transcranial magnetic stimulation (rTMS) is an effective method used in clinical practice for treating patients with MDD. 408”
From Major depressive disorder: hypothesis, mechanism, prevention and treatment (2024) · cites this paper as [408]
In the citing paper
“Most clinical rTMS treatments for MDD occur daily (one rTMS session per day) and are applied using scalp-based targeting of DLPFC. These standard treatments are only modestly effective, even in the general MDD population (17, 24–31).”
In the citing paper
“rTMS of the left side of the dorsolateral prefrontal cortex (DLPFC) at 10 Hz is a well-tolerated, evidence-based treatment for TRD.5”
In the citing paper
“While this intensity is consistent with current recommendations for standard rTMS,5 there is no current consensus on the optimal intensity for TBS and other studies have used lower intensities.12”
Citations
Cites
The PHQ-9: Validity of a brief depression severity measure
Kroenke, K., Spitzer, R. L., & Williams, J. B. W. (2001) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.2001.016009606.x · Cited by 44,910
Rush, A. J., Trivedi, M. H., Wisniewski, S. R., Nierenberg, A. A., Stewart, J. W., Warden, D., Niederehe, G., Thase, M. E., Lavori, P. W., Lebowitz, B. D., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.11.1905 · Cited by 5,643
Rossi, S., Hallett, M., Rossini, P. M., & Pascual-Leone, A. (2009) · Clinical Neurophysiology · doi:10.1016/j.clinph.2009.08.016 · Cited by 5,367
NON-INVASIVE MAGNETIC STIMULATION OF HUMAN MOTOR CORTEX
Barker, A. T., Jalinous, R., & Freeston, I. L. (1985) · The Lancet · doi:10.1016/s0140-6736(85)92413-4 · Cited by 4,460
Rush, A. J., Trivedi, M. H., Ibrahim, H. M., Carmody, T. J., Arnow, B., Klein, D. N., Markowitz, J. C., Ninan, P. T., Kornstein, S., Manber, R., et al. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01866-8 · Cited by 3,829
Wassermann, E. M. (1998) · Electroencephalography and Clinical Neurophysiology/Evoked Potentials Section · doi:10.1016/s0168-5597(97)00096-8 · Cited by 2,293
Lefaucheur, J.-P., André-Obadia, N., Antal, A., Ayache, S. S., Baeken, C., Benninger, D. H., Cantello, R. M., Cincotta, M., de Carvalho, M., De Ridder, D., et al. (2014) · Clinical Neurophysiology · doi:10.1016/j.clinph.2014.05.021 · Cited by 2,119
O’Reardon, J. P., Solvason, H. B., Janicak, P. G., Sampson, S., Isenberg, K. E., Nahas, Z., McDonald, W. M., Avery, D., Fitzgerald, P. B., Loo, C., et al. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.01.018 · Cited by 1,910
Self-citationUsing the International 10-20 EEG System for Positioning of Transcranial Magnetic Stimulation
Herwig, U., Satrapi, P., & Schönfeldt-Lecuona, C. (2003) · Brain Topography · doi:10.1023/b:brat.0000006333.93597.9d · Cited by 1,098
George, M. S., Lisanby, S. H., Avery, D., McDonald, W. M., Durkalski, V., Pavlicova, M., Anderson, B., Nahas, Z., Bulow, P., Zarkowski, P., et al. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.46 · Cited by 1,092 · cited 1×
“…magnetic stimulation device package insert as well as in the US Food and Drug Administration (FDA) 510k application material. b In the study by George et al,10 patients underwent head magnetic resonance imaging with fiducials (vitamin E capsules), which resulted in 33.2% of patients having…”
BackgroundSelf-citation
Cited by
Items 301–400 of 690
Kujovic, M., Benz, D., Riesbeck, M., Bahr, C., Kriegs, C., Reinermann, D., Jänner, M., Neufang, S., Margittai, Z., Kamp, D., et al. (2023) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-023-01692-w · Cited by 10
Vicheva, P., Osborne, C., Krieg, S. M., Ahmadi, R., & Shotbolt, P. (2024) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2024.111147 · Cited by 16
“…the imbalance hypothesis, excitatory high-frequency rTMS has been applied to the left dlPFC and inhibitory low-frequency rTMS to the right, yielding comparable outcomes (Chen et al., 2013), although evidence-based consensus recommendations support targeting the left dlPFC (McClintock et al., 2018).”
ResultClinical effectiveness of non-TMS neurostimulation in depression: Clinical trials from 2010 to 2020
Zugliani, M. M., Fidry, M., Steffen, R. E., Lan, K., Brietzke, E. M., Milev, R. V., Nardi, A. E., & Freire, R. C. R. (2021) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2021.110287 · Cited by 14
Sheen, J., Miron, J., Mansouri, F., Dunlop, K., Russell, T., Zhou, R., Hyde, M., Fox, L., Voetterl, H., Daskalakis, Z. J., et al. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.08.105 · Cited by 14
Sawai, S., Fujikawa, S., Ushio, R., Tamura, K., Ohsumi, C., Yamamoto, R., Murata, S., & Nakano, H. (2022) · Brain Sciences · doi:10.3390/brainsci12111548 · Cited by 12
“its effectiveness has been verified in dementia [14], stroke [15], and depression [16].”
BackgroundTrajectories of suicidal ideation during rTMS for treatment-resistant depression
Zhan, D., Gregory, E., Humaira, A., Wong, H., Klonsky, E. D., Levit, A., Ridgway, L., & Vila‐Rodriguez, F. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.05.109 · Cited by 11
Jiang, G., Song, H., Han, X., Zhang, M., Huang, L., Zhu, J., Sun, B., Yu, Z., & Yang, D. (2024) · Neuroscience Letters · doi:10.1016/j.neulet.2024.137890 · Cited by 12
Jing, J., Wang, Y., Liang, S., Fan, Q., Li, M., Zhang, L., Cao, Y., Wang, Z., Li, R., Liu, H., et al. (2025) · NeuroImage Clinical · doi:10.1016/j.nicl.2025.103902 · Cited by 15
“Repetitive transcranial magnetic stimulation (rTMS) has been a well-established treatment for major depressive disorder (MDD) (McClintock et al., 2018).”
Rose, D., Lyketsos, C. G., Rosenberg, P. B., & Nowrangi, M. A. (2025) · Neurotherapeutics · doi:10.1016/j.neurot.2025.e00788 · Cited by 17
“Neuromodulation techniques are effective treatments for neuro-psychiatric conditions, including depression and obsessive-compulsive disorder [105 – 107].”
Transcranial magnetic stimulation as a diagnostic and therapeutic tool in cerebral palsy
Antczak, J. M. (2021) · Postępy Psychiatrii i Neurologii · doi:10.5114/ppn.2021.110796 · Cited by 9
Albishi, A. M., Alhadlaq, S. A., Altowairqi, R. T., Alharbi, M. F. J., Alsubiheen, A. M., Alosaimi, M. H., Bashir, S., & Alokaily, A. O. (2024) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2024.1352170 · Cited by 10
Crewther, B. T., Kasprzycka, W., Cook, C. J., & Rola, R. (2021) · Neurological Sciences · doi:10.1007/s10072-021-05335-7 · Cited by 10
A narrative review on invasive brain stimulation for treatment-resistant depression
Dandekar, M. P., Díaz, A. P., Rahman, Z., da Silva, R. H., Nahas, Z. H., Aaronson, S. T., Selvaraj, S., Fenoy, A. J., Sanches, M., Soares, J. C., et al. (2022) · Brazilian Journal of Psychiatry · doi:10.1590/1516-4446-2021-1874 · Cited by 13
The role of repetitive transcranial magnetic stimulation therapy in functional bowel disease
Li, G., Lv, T., Jin, B., & Fan, Z. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1249672 · Cited by 9
Pediatric suicide: Review of a preventable tragedy
Greydanus, D. E., Nazeer, A., Qayyum, Z., Patel, D. R., Rausch, R., Hoang, L.-N., Miller, C., Chahin, S. S., Apple, R. W., Saha, G. K., et al. (2024) · Disease-a-Month · doi:10.1016/j.disamonth.2024.101725 · Cited by 13
Kujovic, M., Bahr, C., Riesbeck, M., Benz, D., Wingerter, L., Deiß, M., Margittai, Z., Reinermann, D., Plewnia, C., & Meisenzahl, E. M. (2024) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-024-01901-0 · Cited by 10
Liu, Y., Huang, S., Zhang, X., Liao, H., Liu, W., Zhang, Z., Qu, X., & Wang, Z. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1511930 · Cited by 10
“In recent years, repetitive transcranial magnetic stimulation (rTMS) has received increasing attention from medical professionals, indicating its effectiveness in improving sleep quality or sleep disorders in patients with depressive mood (14, 15).”
Wang, X., Zhang, Z., Li, Y., Gao, Y., & Cao, Q. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.120132 · Cited by 9
PRIDMORE, S. A., Erger, S., & May, T. (2019) · Malaysian Journal of Medical Sciences · doi:10.21315/mjms2019.26.3.8 · Cited by 8
“This was a naturalistic study, and it was prospective in that we set a goal of recruiting 30 patients and accepted every patient who met the MDE inclusion criteria.”
BackgroundMethodInfluentialHejzlar, M., Novák, T., & Bareš, M. (2021) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s303226 · Cited by 9
“There is a clear clinical need for developing other AD treatments and strategies.(7) During the past decades, non-invasive brain stimulation (NIBS) methods such as repetitive transcranial magnetic stimulation (rTMS) and transcranial direct current stimulation (tDCS) have been increasingly used and examined.”
BackgroundKryatova, M. S., Seiner, S. J., Brown, J. C., & Siddiqi, S. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.01.160 · Cited by 8
Bohmeier, B., Cybinski, L. M., Gromer, D., Bellinger, D., Deckert, J., Erhardt, A., Deserno, L., Mühlberger, A., Pauli, P., Polak, T. T., et al. (2024) · Behavioural Brain Research · doi:10.1016/j.bbr.2024.115232 · Cited by 10
“…defined as lowest stimulation intensity that induce visually observable finger twitches in at least five of ten TMS, was determined according to standard clinical practice [56] over the left motor cortex using a MagPro X100 stimulator and an MC-B70 coil (MagVenture GmbH, Willich, Germany).”
Kaczmarczyk, M., Regen, F., Heuser, I., Bajbouj, M., & Hellmann-Regen, J. (2018) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-018-0969-0 · Cited by 7
Tan, X. W., Abdin, E., & Tor, P. C. (2021) · Pilot and Feasibility Studies · doi:10.1186/s40814-021-00845-9 · Cited by 8
“L DLPFC aTMS will be delivered at 120% of the RMT, as measured at the initial session.”
BackgroundInfluentialCabrera, L. Y., Nowak, G. R., McCright, A. M., Achtyes, E. D., & Bluhm, R. L. (2021) · Health Risk & Society · doi:10.1080/13698575.2021.1979194 · Cited by 11
“dence supporting their effectiveness for reducing depressive symptoms in some patients (George et al., 2010; McClintock et al., 2018).”
BackgroundInfluentialMallon, S. D., Walker, K., Bayley, Z., & Griffiths, C. (2021) · Journal of Psychiatric and Mental Health Nursing · doi:10.1111/jpm.12815 · Cited by 9
Yuruk, D., Özger, C., Garzon, J. F., Leffler, J. M., Shekunov, J., Voort, J. L. V., Zaccariello, M. J., Nakonezny, P. A., & Croarkin, P. E. (2023) · PLoS ONE · doi:10.1371/journal.pone.0280010 · Cited by 8
Bastiaens, J., Brown, N., Bermudes, R. A., Juusola, J. L., Bravata, D. M., & Marton, T. F. (2024) · BMC Psychiatry · doi:10.1186/s12888-024-05928-4 · Cited by 8
“In 2017, consensus recommendations for clinical use of TMS for MDD were published [10].”
BackgroundTMS in the Kingdom of Denmark: an overview of current clinical practice
Barata, P. C., Pimenta, S., & Sack, A. T. (2024) · Nordic Journal of Psychiatry · doi:10.1080/08039488.2024.2419620 · Cited by 6
“Repetitive transcranial magnetic stimulation (rTMS) has been demonstrated to be an effective treatment of several neuro-psychiatric disorders, particularly unipolar depression [1,2] and obsessive-compulsive disorder [3,4].”
Influentialvan Hattem, T., Chang, K.-Y., Tik, M., Taylor, P. C. J., Björklund, J., Bulubas, L., Padberg, F., Keeser, D., & Campana, M. (2025) · NeuroImage Clinical · doi:10.1016/j.nicl.2025.103862 · Cited by 10
“High-frequency 10 Hz rTMS over the left dorsolateral prefrontal cortex (DLPFC) has become a FDA-approved clinical standard for treating pharmacoresistant major depressive disorder (MDD) (O’Reardon et al., 2007; Berlim et al., 2014; McClintock et al., 2018; Papakostas et al., 2024).”
Makale, M., Nybo, C., Keifer, J., Blum, K., Dennen, C. A., Baron, D. A., Sunder, K. R., Elman, I., Makale, M. R., Thanos, P. K., et al. (2023) · Brain Sciences · doi:10.3390/brainsci13081179 · Cited by 8
Shou, B., Chen, X., & Hou, Y. (2024) · The International Journal of Psychiatry in Medicine · doi:10.1177/00912174241227513 · Cited by 7
“6 However, there is a limited body of research pertaining to the management of cognitive dysfunction in individuals with cerebral small vessel disease.”
rTMS for post-covid-19 condition: A sham-controlled case series involving iTBS-300 and iTBS-600
Sakib, M. N., Saragadam, A., Santagata, M. C., Jolicoeur-Becotte, M., Kozyr, L., Burhan, A. M., & Hall, P. A. (2024) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2024.100736 · Cited by 8
“Repetitive transcranial magnetic stimulation (rTMS) has been used to treat neuropsychiatric conditions involving challenges with concentration, attention and fatigue, including depression (McClintock et al., 2018) and concussion (Mollica et al., 2021).”
MethodPettorruso, M., Lorenzo, G. D., Benatti, B., d’Andrea, G., Cavallotto, C., Carullo, R., Mancusi, G., Marco, O. D., Mammarella, G., d'Attilio, A., et al. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1436006 · Cited by 10
Pages, K. P., Aaronson, S. T., Carpenter, L. L., Hutton, T. M., Rush, A. J., & Sackeïm, H. A. (2024) · Transcranial magnetic stimulation . · doi:10.1016/j.transm.2024.100075 · Cited by 8
Self-citationPerrino, S., Vazana, U., Prager, O., Schori, L., Ben‐Arie, G., Minarik, A., Chen, Y. M., Haçarız, O., Hashimoto, M., Roth, Y., et al. (2024) · Pharmaceuticals · doi:10.3390/ph17121607 · Cited by 7
Sun, Y., Liu, X., Li, Y., Zhi, Q., & Xia, Y. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1485878 · Cited by 10
Jiang, S., Huang, J., Yang, H., Wagoner, R., Kozel, F. A., Currier, G. W., & Jiang, H. (2021) · Scientific Reports · doi:10.1038/s41598-021-86751-9 · Cited by 9
Giam, A., Chen, L., Hahn, L. A., Gill, S., Clarke, P., Ng, F., Galletly, C. A., & Fitzgerald, P. B. (2021) · Journal of Affective Disorders Reports · doi:10.1016/j.jadr.2021.100162 · Cited by 9
Bastani, P. B., Kordjazi, M., Oveisgharan, S., & Abdi, S. (2021) · Journal of Clinical Neurophysiology · doi:10.1097/wnp.0000000000000874 · Cited by 8
Noninvasive Brain Stimulation Techniques for Treatment-Resistant Depression
Boscutti, A., Figueiredo, J. M. D., Razouq, D., Murphy, N., Cho, R., & Selvaraj, S. (2023) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2023.02.005 · Cited by 12
Neurostimulation therapies in major depressive disorder: A decision‐analytic model
Teng, M., Khoo, A. L., Zhao, Y. J., Abdin, E., Mok, Y. M., Lim, B. P., & Tor, P. C. (2020) · Early Intervention in Psychiatry · doi:10.1111/eip.13091 · Cited by 8
“, 2018) however did not consider indirect cost and failed to include transcranial magnetic stimulation (TMS) which has emerged as an important treatment modality in MDD (McClintock et al., 2018).”
BackgroundNeuromodulation treatments of problematic use of the Internet
Xu, L., Geng, X., Zhang, J., Guo, X.-Y., Potenza, M. N., & Zhang, J. (2022) · Current Opinion in Behavioral Sciences · doi:10.1016/j.cobeha.2022.101215 · Cited by 9
Ørbo, M. C., Grønli, O., Larsen, C., Vangberg, T. R., Friborg, O., Turi, Z., Mittner, M., Csifcsák, G., & Aslaksen, P. M. (2023) · Trials · doi:10.1186/s13063-023-07674-6 · Cited by 9
“…50 Hz bursts repeated at 5 Hz; 2 s on and 8 s off, 600 pulses per session with a total duration of 3 min 9 s. RMT is determined by observable right-handed thumb twitches (musculus abductor pollicis brevis) in three of five trials while delivering stimulation to the left primary motor cortex [57].”
MethodTrajectory Modeling and Response Prediction in Transcranial Magnetic Stimulation for Depression
McInnes, A. N., Olsen, S. T., Sullivan, C. R. P., Cooper, D. C., Wilson, S., Sonmez, A. I., Albott, C. S., Olson, S. C., Peterson, C. B., Rittberg, B. R., et al. (2024) · Personalized Medicine in Psychiatry · doi:10.1016/j.pmip.2024.100135 · Cited by 9
Tang, V. M., Aaronson, S., Abdelghani, M., Baeken, C., Barbour, T. A., Brunoni, A. R., Bulteau, S., Carpenter, L. L., Croarkin, P. E., Daskalakis, Z. J., et al. (2025) · American Journal of Psychiatry · doi:10.1176/appi.ajp.20240403 · Cited by 7
Self-citationNguyen, Q. K. D., Solanki, P., Thomas, E. H. X., Cerins, A., Hahn, L. A., Galletly, C. A., Fitzgerald, P. B., & Chen, L. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.05.033 · Cited by 6
Song, D., Deng, X., Chang, D., Chang, D., & Wang, Z. (2025) · Cerebral Cortex · doi:10.1093/cercor/bhaf171 · Cited by 11
Jiao, J., Tan, L., Zhang, Y., Li, T., & Tang, X. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.977341 · Cited by 7
“rTMS has been used to treat major depression and treatment-resistant depression (17).”
MethodMudunuru, A. K., Reddy, M. S. S., Valipay, K., A, B. S., Madhiha, M., Chandresh, N., Chandrasekhar, K., & Gundugurti, P. R. (2024) · Cureus · doi:10.7759/cureus.60895 · Cited by 13
“The presence of ferromagnetic materials in the head and neck region, a history of traumatic brain injury, and the presence of pacemakers, cochlear implants, or other implanted devices were the clear exclusion criteria [14, 15].”
BackgroundAnalysis of EEG-derived brain networks for predicting rTMS treatment outcomes in MDD patients
Hasanzadeh, F., Mohebbi, M., & Rostami, R. (2024) · Biomedical Signal Processing and Control · doi:10.1016/j.bspc.2024.106613 · Cited by 6
Status and trends of TMS research in depressive disorder: a bibliometric and visual analysis
Yang, J., Tang, T., Gui, Q., Zhang, K., Zhang, A., Wang, T., Yang, C., Liu, X., & Sun, N. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1432792 · Cited by 7
Chung, S.-C., Jo, J.-H., Choi, M., Min, P. K., Yi, J., & Kim, H.-S. (2019) · International Journal of Electrical and Electronic Engineering & Telecommunications · doi:10.18178/ijeetc.8.5.254-261 · Cited by 6
Chen, J., Shen, K., Fan, L., Hu, H., Li, T., Zhang, Y., & Gao, H. (2022) · Frontiers in Psychology · doi:10.3389/fpsyg.2022.923506 · Cited by 8
“These consensus recommendations, developed by the NNDC rTMS Task Group and the APA CoR Task Force on Novel Biomarkers and Treatments, provide comprehensive information for the safe and effective clinical application of rTMS in treating MDD (McClintock et al., 2018).”
MethodParedes-Aragón, E. M., Ruiz‐Garcia, R., & Burneo, J. G. (2023) · Revista de Neurología · doi:10.33588/rn.7604.2022386 · Cited by 11
“La estimulación magnética transcraneal repetitiva es un tratamiento aprobado para la depresión [66].”
Makale, M. T., Nybo, C., Blum, K., Dennen, C. A., Elman, I., & Murphy, K. T. (2024) · Journal of Personalized Medicine · doi:10.3390/jpm14080857 · Cited by 9
“Subjects were required to have stable medication and ABA regimes for at least 8 weeks prior to commencing PrTMS treatment study enrollment and to have satisfied well-established rTMS safety and exclusion criteria [58–60].”
MethodTreatment-Resistant Depression Among US Military Veterans
Lande, R. G. (2019) · Springer eBooks · doi:10.1007/978-3-030-05384-0_7 · Cited by 6
Neurophysiological Model of Migraine Pathophysiology: Bringing the Past into the Future
Coppola, G., Pierelli, F., Schoenen, J. E., Wang, S., & Chen, W. (2020) · Headache · doi:10.1007/978-3-030-56538-1_17 · Cited by 7
Management of Treatment-Resistant Depression in Real-World Clinical Practice Settings Across Asia
Wang, G., Han, C., Liu, C.-Y., Chan, S. S. M., Kato, T., Tan, W., Zhang, L., Feng, Y., & Ng, C. H. (2020) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s264813 · Cited by 6
Troubles de l’humeur : quand recourir à la stimulation magnétique transcrânienne ?
Bulteau, S., Guirette, C., Brunelin, J., Poulet, E., Trojak, B., Richieri, R. M., Szekely, D., Bennabi, D., Yrondi, A., Rothärmel, M., et al. (2019) · La Presse Médicale · doi:10.1016/j.lpm.2019.01.012 · Cited by 8
Novel NIBS in psychiatry: Unveiling TUS and TI for research and treatment
Sharif, F., Harmer, C. J., Klein-Flügge, M. C., & Tan, H. (2025) · Brain and Neuroscience Advances · doi:10.1177/23982128251322241 · Cited by 5
“…countries, including Canada, Australia and Germany, reflecting its global recognition as a viable therapy for treatment-resistant depression (Bourla et al., 2020; McClintock et al., 2018). rTMS is a non-invasive technique that employs repeated low-intensity magnetic pulses to targeted brain areas.”
Bacila, C. I., Cornea, M., Lomnășan, A., Anghel, C. E., Grama, A. M., Dobre, C. E., Rusu, S., & Vintilă, B. I. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14103609 · Cited by 7
Tao, Y., Duan, X., Liu, P., Wang, M., Li, S.-X., Luo, T.-T., Xing, H., & Huang, Y. C. (2025) · World Journal of Pediatrics · doi:10.1007/s12519-025-00983-7 · Cited by 6
“Given these challenges, attention has turned to repetitive transcranial magnetic stimulation (rTMS) as a novel approach to treating depression in youth. rTMS is a non-invasive neuromodulation technique well-established in adult depressive disorder [12].”
Wang, Y., Pan, Y., Shu, H., Zhang, L.-J., Li, Q., Ge, Q., Liang, R., & Shao, Y. (2022) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2022.790678 · Cited by 5
“In addition, TMS can also be used in learning, memory, language, and emotional research (Brunoni et al., 2017; Sebastianelli et al., 2017; McClintock et al., 2018; Arns et al., 2019; Yang et al., 2019; Chou et al., 2020; Malkani and Zee, 2020).”
BackgroundArora, S. K., Faaez, A., Pyda, P. K., Suhas, S., Sreeraj, V. S., Mehta, U. M., & John, J. P. (2024) · Brain stimulation · doi:10.1016/j.brs.2024.06.002 · Cited by 5
“Safety considerations for 1800 pulses/session of supra-threshold sequential TBS over DLPFC have been emphasized in literature [2].”
MethodStrategies to mitigate scalp discomfort during repetitive transcranial magnetic stimulation
Lissemore, J. I., Buchanan, D. M., Batail, J.-M. V., Kaloiani, I., Veerapal, C., Sahlem, G. L., & Williams, N. (2024) · Brain stimulation · doi:10.1016/j.brs.2024.09.004 · Cited by 5
“Alternatively, topical lidocaine, scalp cooling with ice, and administration of ibuprofen/acetaminophen are non-invasive strategies that have been reported upon as strategies to enhance rTMS tolerability [2,6 – 8].”
BackgroundStimulation Effects Mapping for Optimizing Coil Placement for Transcranial Magnetic Stimulation
Zhong, G., Jin, F., Ma, L., Yang, Y., Zhang, B., Cao, D., Jin, L., Zuo, N., Fan, L., Yang, Z., et al. (2025) · Neuroinformatics · doi:10.1007/s12021-024-09714-1 · Cited by 5
“Transcranial magnetic stimulation (TMS) is an effective and non-invasive technique to assess and modulate cortical excitability (McClintock et al., 2018; Ni and Chen, 2015; Walsh and Cowey, 2000).”
Hwang, J. H., Hwang, H., Kim, H. R., Hong, J. S., Han, D. H., Shin, J., Kim, S. H., & Kim, S. M. (2020) · Journal of Korean Medical Science · doi:10.3346/jkms.2020.35.e205 · Cited by 7
Zeng, S., Tang, C., Su, M., Luo, X., Liang, H., Yang, L., & Zhang, B. (2022) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2022.152332 · Cited by 5
Vidya, K. L., Srivastava, S., Singh, B. P., & Kar, S. K. (2022) · CNS Spectrums · doi:10.1017/s1092852922001018 · Cited by 5
“Consensus recommendation for clinical application of TMS in depression has recommended that HF-rTMS be avoided in patients with risk of seizure like history of stroke, electrolyte imbalance which occur more frequently among elderly.(17) Low-frequency rTMS is relatively safer but less efficacious.”
BackgroundDiagnosis of Depression Based on New Features Extractive from the Frequency Space of the EEG
Changizi, M., & Rashidi, S. (2023) · International Conference on Computer and Knowledge Engineering · doi:10.1109/iccke60553.2023.10326222 · Cited by 5
“Therefore, we discuss a new implementation of neurofeedback training (NFBt) [21], electroconvulsive therapy (ECT) [22], repetitive transcranial magnetic stimulation (rTMS) [23], and deep brain stimulation (DBS) [24] based on these results for future research.”
BackgroundCunningham, J. E., Bluhm, R. L., Achtyes, E. D., McCright, A. M., & Cabrera, L. Y. (2023) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2023.12.013 · Cited by 6
Hung, K.-C., Cheng, C.-M., Liang, S.-C., Sun, C.-K., Chen, C.-M., Cheng, Y., & Chiu, H. (2024) · Brazilian Journal of Psychiatry · doi:10.47626/1516-4446-2023-3428 · Cited by 8
Non-invasive Neuromodulation of Arrhythmias
Rast, J. J., Sohinki, D., & Warner, A. M. (2024) · Journal of Innovations in Cardiac Rhythm Management · doi:10.19102/icrm.2024.15022 · Cited by 7
“67 .”
Stubbeman, W. F., Yang, J., Converse, J., Gencosmanoglu, M., Ortega, D. M., Morris, J., Sobocinski, A., Li, V., Gunawardane, G., Edelen, Y., et al. (2024) · Brain Sciences · doi:10.3390/brainsci14050483 · Cited by 6
“These may include a history of seizure, the presence of metallic implants above the shoulder, excluding those inside the mouth, and active psychosis [17].”
BackgroundMethodNiemrungruang, K., Thanakamchokchai, J., Pongmala, C., & Khobkhun, F. (2024) · Physiotherapy Research International · doi:10.1002/pri.2105 · Cited by 7
“Moreover, stimulation of the DLPFC shows enhancements in depression assessment scores, potentially contributing to mitigation of depressive symptoms (McClintock et al., 2018).”
Fardadi, M., Leiter, J. C., Lu, D. C.-T., & Iwasaki, T. (2024) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1012237 · Cited by 6
“…neurons, which was essential to mitigate observed abnormalities of bladder function in patients after SCI within the model, may explain why low frequency TMS leads to reduced cortical excitability and high frequency TMS increased cortical excitability in treating depressive disorders [73].”
BackgroundMaintenance Repetitive Transcranial Magnetic Stimulation for Major Depressive Disorder
Akram, S., Nanji, I., Deniz, I. E., Akram, F., & Mukhtar, F. (2024) · Journal of Ect · doi:10.1097/yct.0000000000001064 · Cited by 5
A Review of Treatment Modalities for Comorbid Neuropathic Pain and Depression
Chen, Z., Cheng, T., Yang, H., Gao, Y., & Ma, X. (2025) · Journal of Integrative Neuroscience · doi:10.31083/jin26523 · Cited by 6
Kelkar, R. S., Sreeraj, V. S., Mehta, U. M., Patwardhan, A., Thirthalli, J., & Blumberger, D. M. (2023) · Brain stimulation · doi:10.1016/j.brs.2023.04.009 · Cited by 5
“As the stimulation intensity used for TBS ranges from 80% to the FDA cleared 120% for iTBS, the uninterrupted train of 40s or longer might be related to increased risk of seizures in predisposed individuals or who have increase in the cortical excitability in the underlying tissue [12].”
BackgroundMelder, A., Wittmann, E., Bulubas, L., Dornheim, B., Kerber, K., Vogelmann, U., Campana, M., Hubert, J., Schmidt, V., Heinen, F., et al. (2023) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2023.10.004 · Cited by 6
Ge, L., McInnes, A. N., Widge, A. S., & Parhi, K. K. (2024) · Journal of Signal Processing Systems · doi:10.1007/s11265-024-01921-y · Cited by 5
Jiang, L., Fung, C. W., & Cheng, C. P. W. (2026) · Frontiers in Neuroimaging · doi:10.3389/fnimg.2025.1703198 · Cited by 5
Laufer, J., Olmsted, A. M., Sampair, I., Madore, M. R., Yoon, J. H., Hack, L. M., & Keller, C. J. (2024) · Journal of Affective Disorders Reports · doi:10.1016/j.jadr.2024.100801 · Cited by 5
Lee, N. A., Kung, S., Penaluna, B. K., Greenwaldt, S. E., Croarkin, P. E., & Lapid, M. I. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.12.012 · Cited by 4
Xing, H., Liu, X., Zhang, Y., Wu, J., Li, M., Ye, H., Ding, Y., Wang, W., Zheng, Z., & Bao, T. (2025) · Reviews in the Neurosciences · doi:10.1515/revneuro-2024-0151 · Cited by 6
Rayani, K., Grabovac, A. D., Chan, P., Montgomery, S., Ghovanloo, M., & Sacchet, M. D. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1494567 · Cited by 9
Safety and efficacy of Deep TMS for adolescent depression based on large real-world data analysis
Roth, Y., Tendler, A., Pell, G. S., Tripp, T., Yam, P., Dekeyser, D., Mekolle, M., Tripp, J., Dahl, A. J., Muir, O. S., et al. (2025) · Psychiatry Research · doi:10.1016/j.psychres.2025.116567 · Cited by 6
“…its 2008 FDA clearance, rTMS therapy has been administered to approximately 1.5 million U.S. patients, gaining acceptance due to its efficacy, safety profile, and insurance coverage (Bastiaens et al., 2024; McClintock et al., 2018; Sackeim et al., 2020; Tendler et al., 2023; Weissman et al., 2023).”
InfluentialAlexandersen, A., Aasen, S. R., Csifcsák, G., & Mittner, M. (2025) · Cortex · doi:10.1016/j.cortex.2025.07.006 · Cited by 6
Brihmat, N., Allexandre, D., Bayram, M. B., Saleh, S., Guan, X., Yue, G. H., Zhong, J., & Forrest, G. F. (2022) · Journal of Neurophysiology · doi:10.1152/jn.00268.2022 · Cited by 4
Balzekas, I., Lewis, C. P., Shekunov, J., Port, J. D., Worrell, G. A., Jo, H. J., & Croarkin, P. E. (2018) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2018.05.013 · Cited by 4
Novel Neuromodulatory Approaches for Depression: Neurobiological Mechanisms
Bulubas, L., Mezger, E., Keeser, D., Padberg, F., & Brunoni, A. R. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813333-0.00031-7 · Cited by 5
Li, S., Wang, Y., Li, S., Lv, Y., Zhang, L., Zou, J., & Ma, L. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00858 · Cited by 4
“Certain effects have been achieved in the treatment of nervous system diseases such as depression (McClintock et al., 2018), central cord syndrome (Choi et al.”
BackgroundNeurophysiological Bases and Mechanisms of Action of Transcranial Magnetic Stimulation
Lazzaro, V. D., & Falato, E. (2020) · Springer eBooks · doi:10.1007/978-3-030-43356-7_2 · Cited by 6
Miron, J., Sheen, J., Panzarella, T., Hyde, M., Mansouri, F., Fox, L., Voetterl, H., Jodoin, V. D., Lespérance, P., Longpré-Poirier, C., et al. (2021) · Journal of Affective Disorders Reports · doi:10.1016/j.jadr.2021.100270 · Cited by 5
Hong, H., Kim, R. Y., Song, Y., Suh, C., Lee, H., Lyoo, I. K., Yoon, S. J., Lim, S. M., & Lee, S. L. (2022) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-022-01436-2 · Cited by 5
“With regards to the localization of stimulation, the current study implemented an approximation method, which is known to efficiently localize the F3 position based on the international 10–20 system [45].”
BackgroundMethodReport of seizure induced by intermittent theta burst stimulation
Ferguson, J., Huffman, S., Parmar, S., Blankenship, A., Brown, T. R., & George, M. S. (2022) · Brain stimulation · doi:10.1016/j.brs.2022.09.007 · Cited by 4
“” [6] There is at least one reported case of seizure induced by theta burst in a patient without risk factorsdthough this was continuous stimulation rather than intermittent, as was used on our subject [7].”
Self-citationYoung, I. M., Osipowicz, K. Z., Mackenzie, A., Clarke, O., Taylor, H. M., Nicholas, P. J., Ryan, M., Holle, J., Tanglay, O., Doyen, S., et al. (2022) · Brain stimulation · doi:10.1016/j.brs.2022.10.008 · Cited by 5
“These approaches to craniometric targeting are widely used in the field, and the principal reason given for their use over image guidance-based approaches is based on cost considerations, as using image guidance requires the purchase of additional equipment [2].”
Makale, M., Blum, K., Bowirrat, A., Sunder, K. R., Makale, M. R., Gold, M. S., Elman, I., Dennen, C. A., & Murphy, K. T. (2024) · Medical Hypotheses · doi:10.1016/j.mehy.2024.111333 · Cited by 7
Seybert, C., Cotovio, G., Grácio, J., & Oliveira-Maia, A. J. (2021) · Frontiers in Psychology · doi:10.3389/fpsyg.2021.728130 · Cited by 4
Metadata
- Authors
- McClintock, S. M., Reti, I. M., Carpenter, L. L., McDonald, W. M., Dubin, M., Taylor, S. F., Cook, I. A., O’Reardon, J., Husain, M. M., Wall, C., Krystal, A. D., Sampson, S. M., Morales, O., Nelson, B. G., Latoussakis, V., George, M. S., Lisanby, S. H., & on behalf of both the National Network of Depression Centers rTMS Task Group and the American Psychiatric Association Council on Research Task Force on Novel Biomarkers and Treatments
- Affiliations
- Duke University (US)
- Johns Hopkins University (US)
- Butler Hospital (US)
- Emory University (US)
- Weill Cornell Medicine (US)
- University of Michigan (US)
- University of California, Los Angeles (US)
- American Psychiatric Association (US)
- Mayo Clinic (US)
- Harvard University (US)
- University of Minnesota (US)
- Medical University of South Carolina (US)
- Corresponding author
- McClintock, Shawn M.
- ORCID
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 2018-02-21
- Volume
- 79
- Issue
- 1
- Pages
- 35-48
- ISSN
- 0160-6689 (ISSN-L)
- PMC
- PMC5846193
- OpenAlex
- W2617605873
- Cited by
- 693
- References
- 120
- Citations by year
- 2026: 77 · 2025: 94 · 2024: 108 · 2023: 82 · 2022: 85 · 2021: 98 · 2020: 66 · 2019: 54 · 2018: 22
- FWCI
- 20.18
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- The Journal of Clinical Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- National Institutes of Health (UL1TR002384)
- National Institute of Mental Health (K23MH087739)
- National Center for Advancing Translational Sciences
- Topics
- Life Sciences › Neuroscience › Neurology › Transcranial Magnetic Stimulation Studies
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Electroconvulsive Therapy Studies
- Keywords
- repetitive transcranial magnetic stimulation, major depressive disorder, depression treatment, expert consensus recommendations, antidepressant treatment
- MeSH terms
- Contraindications, Major Depressive Disorder, Humans, Transcranial Magnetic Stimulation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.